Axsome Therapeutics, Inc.
US ˙ NasdaqGM ˙ US05464T1043

SecurityAXSM / Axsome Therapeutics, Inc.
InstitutionWolverine Trading, Llc
Latest Disclosed Ownership18,157 shares
Latest Disclosed Value $ 2,135,626
Wolverine Trading, Llc ownership in AXSM / Axsome Therapeutics, Inc.

On November 14, 2025 - Wolverine Trading, Llc filed a 13F-HR form disclosing ownership of 18,157 shares of Axsome Therapeutics, Inc. (US:AXSM) valued at $2,205,168 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 18, 2025 disclosing 17,609 shares of Axsome Therapeutics, Inc.. This represents a change in shares of 3.11% during the quarter. The current value of the position is $4,202,982 USD.

Wolverine Trading, Llc has a history of taking positions in derivatives of the underlying security (AXSM) in the form of stock options. The firm currently holds call options representing 25,900 of underlying shares valued at $3,046,358 USD and put options representing 27,900 of underlying shares valued at $3,281,598 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AXSM / Axsome Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F AXSOME THERAPEUTICS COM 05464T104 18,157 548 3.11 2,136 17.31 0.0015
2025-08-18 2025-06-30 13F AXSOME THERAPEUTICS COM 05464T104 17,609 8,743 98.61 1,820 73.33 0.0018
2025-05-15 2025-03-31 13F AXSOME THERAPEUTICS COM 05464T104 8,866 -2,256 -20.28 1,051 11.46 0.0012
2025-02-14 2024-12-31 13F AXSOME THERAPEUTICS COM 05464T104 11,122 -2,928 -20.84 943 -25.18 0.0009
2024-11-14 2024-09-30 13F AXSOME THERAPEUTICS COM 05464T104 14,050 14,050 1,259 0.0013
2024-08-14 2024-06-30 13F AXSOME THERAPEUTICS COM 05464T104 0 -3,885 -100.00 0 -100.00
2024-05-15 2024-03-31 13F AXSOME THERAPEUTICS COM 05464T104 3,885 -1,173 -23.19 310 -22.89 0.0003
2024-02-14 2023-12-31 13F AXSOME THERAPEUTICS COM 05464T104 5,058 -534 -9.55 403 3.08 0.0004
2023-11-15 2023-09-30 13F AXSOME THERAPEUTICS COM 05464T104 5,592 -2,227 -28.48 391 -31.70 0.0004
2023-08-23 2023-06-30 13F AXSOME THERAPEUTICS COM 05464T104 7,819 7,819 572 0.0007
2023-05-15 2023-03-31 13F AXSOME THERAPEUTICS COM 05464T104 0 -3,920 -100.00 0 -100.00
2023-02-14 2022-12-31 13F AXSOME THERAPEUTICS COM 05464T104 3,920 -2,659 -40.42 302 4.14 0.0005
2022-11-14 2022-09-30 13F AXSOME THERAPEUTICS COM 05464T104 6,579 6,579 290 0.0005
2016-11-14 2016-09-30 13F AXSOME THERAPEUTICS COM 05464T104 0 -12 -100.00 0 -100.00 0.0000
2016-08-15 2016-06-30 13F AXSOME THERAPEUTICS COM 05464T104 12 12 0 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F AXSOME THERAPEUTICS COM Call 25,900 70.39 3,046 93.89 n/a n/a n/a
2025-08-18 2025-06-30 13F AXSOME THERAPEUTICS COM Call 15,200 -52.05 1,571 -58.18 n/a n/a n/a
2025-05-15 2025-03-31 13F AXSOME THERAPEUTICS COM Call 31,700 -38.68 3,757 -14.28 n/a n/a n/a
2025-02-14 2024-12-31 13F AXSOME THERAPEUTICS COM Call 51,700 56.67 4,383 48.17 n/a n/a n/a
2024-11-14 2024-09-30 13F AXSOME THERAPEUTICS COM Call 33,000 62.56 2,958 81.03 n/a n/a n/a
2024-08-14 2024-06-30 13F AXSOME THERAPEUTICS COM Call 20,300 28.48 1,634 29.68 n/a n/a n/a
2024-05-15 2024-03-31 13F AXSOME THERAPEUTICS COM Call 15,800 -37.80 1,261 -37.65 n/a n/a n/a
2024-02-14 2023-12-31 13F AXSOME THERAPEUTICS COM Call 25,400 57.76 2,022 79.64 n/a n/a n/a
2023-11-15 2023-09-30 13F AXSOME THERAPEUTICS COM Call 16,100 -38.08 1,125 -40.82 n/a n/a n/a
2023-08-23 2023-06-30 13F AXSOME THERAPEUTICS COM Call 26,000 -13.91 1,901 190,000.00 n/a n/a n/a
2023-05-15 2023-03-31 13F AXSOME THERAPEUTICS COM Call 30,200 -5.62 2 -99.96 n/a n/a n/a
2023-02-14 2022-12-31 13F AXSOME THERAPEUTICS COM Call 32,000 26.98 2,468 121.74 n/a n/a n/a
2022-11-14 2022-09-30 13F AXSOME THERAPEUTICS COM Call 25,200 1,113 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F AXSOME THERAPEUTICS COM Put 27,900 48.40 3,282 68.86 n/a n/a n/a
2025-08-18 2025-06-30 13F AXSOME THERAPEUTICS COM Put 18,800 6.21 1,943 -7.34 n/a n/a n/a
2025-05-15 2025-03-31 13F AXSOME THERAPEUTICS COM Put 17,700 -49.86 2,098 -29.91 n/a n/a n/a
2025-02-14 2024-12-31 13F AXSOME THERAPEUTICS COM Put 35,300 96.11 2,993 85.49 n/a n/a n/a
2024-11-14 2024-09-30 13F AXSOME THERAPEUTICS COM Put 18,000 6.51 1,614 18.60 n/a n/a n/a
2024-08-14 2024-06-30 13F AXSOME THERAPEUTICS COM Put 16,900 -1.17 1,360 -0.29 n/a n/a n/a
2024-05-15 2024-03-31 13F AXSOME THERAPEUTICS COM Put 17,100 -26.61 1,365 -26.43 n/a n/a n/a
2024-02-14 2023-12-31 13F AXSOME THERAPEUTICS COM Put 23,300 15.35 1,854 31.40 n/a n/a n/a
2023-11-15 2023-09-30 13F AXSOME THERAPEUTICS COM Put 20,200 -7.34 1,412 -11.48 n/a n/a n/a
2023-08-23 2023-06-30 13F AXSOME THERAPEUTICS COM Put 21,800 3.32 1,594 159,300.00 n/a n/a n/a
2023-05-15 2023-03-31 13F AXSOME THERAPEUTICS COM Put 21,100 -11.72 1 -99.95 n/a n/a n/a
2023-02-14 2022-12-31 13F AXSOME THERAPEUTICS COM Put 23,900 -8.78 1,843 59.29 n/a n/a n/a
2022-11-14 2022-09-30 13F AXSOME THERAPEUTICS COM Put 26,200 1,157 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.